Crystal3 Labs acquired by Vithalbhai Dhaduk

Monday, December 19, 2011 10:42 AM

Crystal3 Labs, a cGMP contract research organization based in Boca
Raton, FL, has been acquired by an individual investor, Vithalbhai Dhaduk, M.D., of Fargo, ND. Financial terms of the transaction were not disclosed. The company will also change its name to Global Pharma Analytics.

Founded in 2007, Global Pharma Analytics provides pharmaceutical research
services and analytical testing of drugs and medical devices for the pharmaceutical and biotechnology industries. The company employs 6 people
in Florida.

Dr. Dhaduk serves as chairman of several biotech companies he cofounded. He is also an actively practicing neurologist and is currently chief of neurology at the Community Medical Center in Scranton, PA.

"Our name change reflects our increased investment in developing CRO services to meet the needs of pharmaceutical and biotechnology companies conducting research around the world. We look forward to working closely with Dr. Dhaduk, as his wisdom and extensive industry experience will be very valuable to us and to our clients,"  said Satish Chandran, Ph.D., chief executive officer at Global Pharma.

Share:          
CWWeekly

April 20

Christie Clinic, PMG Research's 12th clinical research site, expands its geographic reach north to Illinois

Clinipace acquires Accovion to expand European presence, following an infusion of equity that could lead to more deals

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs